These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8385078)

  • 1. Conformational analysis of mu-selective [D-Ala2,MePhe4]enkephalins.
    Penkler LJ; Van Rooyen PH; Wessels PL
    Int J Pept Protein Res; 1993 Mar; 41(3):261-74. PubMed ID: 8385078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct differences between morphine- and [D-Ala2,N-MePhe4,Gly-ol5]-enkephalin-mu-opioid receptor complexes demonstrated by cyclic AMP-dependent protein kinase phosphorylation.
    Chakrabarti S; Law PY; Loh HH
    J Neurochem; 1998 Jul; 71(1):231-9. PubMed ID: 9648870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of [D-Ala2,MePhe4,Gly-ol5]enkephalin and [D-Ala2,D-Leu5]enkephalin on ion and amino acid transport in rabbit ileum.
    Meyer G; Botta G; Tavani A; Algeri S; Cremaschi D
    J Pharm Pharmacol; 1989 Jul; 41(7):494-5. PubMed ID: 2570860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single residue, Lys108, of the delta-opioid receptor prevents the mu-opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor.
    Minami M; Nakagawa T; Seki T; Onogi T; Aoki Y; Katao Y; Katsumata S; Satoh M
    Mol Pharmacol; 1996 Nov; 50(5):1413-22. PubMed ID: 8913373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential modulation of mu-opioid receptor-mediated antitussive activity by delta-opioid receptor agonists in mice.
    Kamei J; Iwamoto Y; Suzuki T; Nagase H; Misawa M; Kasuya Y
    Eur J Pharmacol; 1993 Mar; 234(1):117-20. PubMed ID: 8386091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sites.
    Rothman RB; Bykov V; Long JB; Brady LS; Jacobson AE; Rice KC; Holaday JW
    Eur J Pharmacol; 1989 Jan; 160(1):71-82. PubMed ID: 2540993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation by enkephalins of D-glucose absorption in rabbit ileum.
    Meyer G; Bottà G; Cremaschi D
    Cell Mol Life Sci; 1997 Sep; 53(9):769-75. PubMed ID: 9368674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of mu- and delta- opioid receptors on the intestinal propulsion in rats.
    Sbacchi M; La Regina A; Petrillo P; Tavani A
    NIDA Res Monogr; 1986; 75():520-3. PubMed ID: 2828999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution conformations of the peptide backbone for DPDPE and its beta-MePhe4-substituted analogs.
    Nikiforovich GV; Prakash OM; Gehrig CA; Hruby VJ
    Int J Pept Protein Res; 1993 Apr; 41(4):347-61. PubMed ID: 8496017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of mu-opioid receptor-mediated presynaptic inhibition in the rat hippocampus in vitro.
    Capogna M; Gähwiler BH; Thompson SM
    J Physiol; 1993 Oct; 470():539-58. PubMed ID: 8308742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opiate receptor binding characteristics of dimeric analogues of mu-selective DAGO-enkephalin.
    Shimohigashi Y; Waki M; Izumiya N; Costa T; Herz A; Kurono M; Yagi K
    Biochem Int; 1986 Aug; 13(2):199-203. PubMed ID: 3021160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracerebroventricular N-ethylmaleimide differentially reduces supraspinal opioid analgesia in mice.
    Sánchez-Blázquez P; Ulibarri I; Garzón J
    Eur J Pharmacol; 1989 Jul; 166(2):193-200. PubMed ID: 2676563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of FK 33-824 and other enkephalin analogues to peptidase degradation.
    Huguenin R; Maurer R
    Brain Res Bull; 1980; 5(1):47-50. PubMed ID: 6988046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioids binding mu and delta receptors exhibit diverse efficacy in the activation of Gi2 and G(x/z) transducer proteins in mouse periaqueductal gray matter.
    Garzón J; García-España A; Sánchez-Blázquez P
    J Pharmacol Exp Ther; 1997 Apr; 281(1):549-57. PubMed ID: 9103543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mastoparan reduces the supraspinal analgesia mediated by mu/delta-opioid receptors in mice.
    Sánchez-Blázquez P; Garzón J
    Eur J Pharmacol; 1994 Jun; 258(1-2):159-62. PubMed ID: 7925596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to the cloned mu-opioid receptor detect various molecular weight forms in areas of mouse brain.
    Garzon J; Juarros JL; Castro MA; Sanchez-Blazquez P
    Mol Pharmacol; 1995 Apr; 47(4):738-44. PubMed ID: 7723734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six highly active mu-selective opioid peptides identified from two synthetic combinatorial libraries.
    Dooley CT; Kaplan RA; Chung NN; Schiller PW; Bidlack JM; Houghten RA
    Pept Res; 1995; 8(3):124-37. PubMed ID: 7670227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain sites involved in mu-opioid receptor-mediated actions: a 2-deoxyglucose study.
    Fabian I; Ableitner A
    Brain Res; 1995 Oct; 697(1-2):205-15. PubMed ID: 8593578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.